Insiders · Profile

Omega Fund VI, L.P.

10% owner at Lexeo Therapeutics · Former 10% Owner at SPRUCE BIOSCIENCES. Filing since 14 Oct 2020. CIK 0001757917

Company
Date
Role
Action
Shares
Amount
Of holding
7 Nov 2023
10% owner
Bought
454,545
$5.00M
26.7%
14 Oct 2020
Former 10% Owner
Bought
250,000
$3.75M
13.1%
2 decisions on file.